|
1
|
Roncucci L and Mariani F: Prevention of
colorectal cancer: How many tools do we have in our basket? Eur J
Intern Med. 26:752–756. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu KC, Shih TY, Kuo CL, Ma YS, Yang JL,
Wu PP, Huang YP, Lai KC and Chung JG: Sulforaphane induces cell
death through G2/M Phase arrest and triggers apoptosis in HCT 116
human colon cancer cells. Am J Chin Med. 44:1289–1310. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nautiyal J, Banerjee S, Kanwar SS, Yu Y,
Patel BB, Sarkar FH and Majumdar AP: Curcumin enhances
dasatinib-induced inhibition of growth and transformation of colon
cancer cells. Int J Cancer. 128:951–961. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin WW and Karin M: A cytokine-mediated
link between innate immunity, inflammation, and cancer. J Clin
Invest. 117:1175–1183. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
George VC, Dellaire G and Rupasinghe HPV:
Plant flavonoids in cancer chemoprevention: Role in genome
stability. J Nutr Biochem. 45:1–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mukhtar H: Chemoprevention: Making it a
success story for controlling human cancer. Cancer Lett.
326:123–127. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lim HS, Kang YJ, Sung B, Kim SH, Kim MJ,
Kim HR, Kim SJ, Choi YH, Moon HR, Chung HY, et al: Novel
dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivative, MHY-449,
induces cell cycle arrest and apoptosis via the downregulation of
Akt in human lung cancer cells. Oncol Rep. 34:2431–2438.
2015.PubMed/NCBI
|
|
8
|
Goldar S, Khaniani MS, Derakhshan SM and
Baradaran B: Molecular mechanisms of apoptosis and roles in cancer
development and treatment. Asian Pac J Cancer Prev. 16:2129–2144.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fulda S: Tumor resistance to apoptosis.
Int J Cancer. 124:511–515. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fulda S: Targeting apoptosis for
anticancer therapy. Semin Cancer Biol. 31:84–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee Y, Sung B, Kang YJ, Kim DH, Jang JY,
Hwang SY, Kim M, Lim HS, Yoon JH, Chung HY, et al: Apigenin-induced
apoptosis is enhanced by inhibition of autophagy formation in
HCT116 human colon cancer cells. Int J Oncol. 44:1599–1606.
2014.PubMed/NCBI
|
|
12
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McIlwain DR, Berger T and Mak TW: Caspase
functions in cell death and disease. Cold Spring Harb Perspect
Biol. 5:a0086562013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu G, Zheng J, Song E, Donovan M, Zhang
K, Liu C and Tan W: Self-assembled, aptamer-tethered DNA nanotrains
for targeted transport of molecular drugs in cancer theranostics.
Proc Natl Acad Sci USA. 110:7998–8003. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gonçalves C, Martins-Neves SR,
Paiva-Oliveira D, Oliveira VE, Fontes-Ribeiro C and Gomes CM:
Sensitizing osteosarcoma stem cells to doxorubicin-induced
apoptosis through retention of doxorubicin and modulation of
apoptotic-related proteins. Life Sci. 130:47–56. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsang WP, Chau SP, Kong SK, Fung KP and
Kwok TT: Reactive oxygen species mediate doxorubicin induced
p53-independent apoptosis. Life Sci. 73:2047–2058. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dembinski JL and Krauss S:
Characterization and functional analysis of a slow cycling stem
cell-like subpopulation in pancreas adenocarcinoma. Clin Exp
Metastasis. 26:611–623. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi Y, Moon M, Dawood S, McManus B and Liu
PP: Mechanisms and management of doxorubicin cardiotoxicity. Herz.
36:296–305. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu
YL, Liu LF and Yeh ET: Identification of the molecular basis of
doxorubicin-induced cardiotoxicity. Nat Med. 18:1639–1642. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vong LB and Nagasaki Y: Combination
treatment of murine colon cancer with doxorubicin and redox
nanoparticles. Mol Pharm. 13:449–455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
De U, Chun P, Choi WS, Lee BM, Kim ND,
Moon HR, Jung JH and Kim HS: A novel anthracene derivative, MHY412,
induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast
cancer cells through cell cycle arrest and downregulation of
P-glycoprotein expression. Int J Oncol. 44:167–176. 2014.PubMed/NCBI
|
|
22
|
Szwed M, Laroche-Clary A, Robert J and
Jozwiak Z: Efficacy of doxorubicin-transferrin conjugate in
apoptosis induction in human leukemia cells through reactive oxygen
species generation. Cell Oncol (Dordr). 39:107–118. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marengo B, Nitti M, Furfaro AL, Colla R,
Ciucis CD, Marinari UM, Pronzato MA, Traverso N and Domenicotti C:
Redox homeostasis and cellular antioxidant systems: Crucial players
in cancer growth and therapy. Oxid Med Cell Longev.
2016:62356412016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Renschler MF: The emerging role of
reactive oxygen species in cancer therapy. Eur J Cancer.
40:1934–1940. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arion D, Meijer L, Brizuela L and Beach D:
cdc2 is a component of the M phase-specific histone H1 kinase:
Evidence for identity with MPF. Cell. 55:371–378. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bates S, Ryan KM, Phillips AC and Vousden
KH: Cell cycle arrest and DNA endoreduplication following
p21Waf1/Cip1 expression. Oncogene. 17:1691–1703. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Amendola A, Fesus L, Piacentini M and
Szondy Z: ‘Tissue’ transglutaminase in AIDS. J Immunol Methods.
265:145–159. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zamzami N, Marchetti P, Castedo M,
Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B and
Kroemer G: Sequential reduction of mitochondrial transmembrane
potential and generation of reactive oxygen species in early
programmed cell death. J Exp Med. 182:367–377. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pelicano H, Carney D and Huang P: ROS
stress in cancer cells and therapeutic implications. Drug Resist
Updat. 7:97–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Santoro V, Jia R, Thompson H, Nijhuis A,
Jeffery R, Kiakos K, Silver AR, Hartley JA and Hochhauser D: Role
of reactive oxygen species in the abrogation of oxaliplatin
activity by cetuximab in colorectal cancer. J Natl Cancer Inst.
108:djv3942015. View Article : Google Scholar : PubMed/NCBI
|
